Novel markers for poor prognosis in head and neck cancer
Open Access
- 8 December 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 113 (5), 789-797
- https://doi.org/10.1002/ijc.20608
Abstract
Head and neck cancer (HNSCC) is one of the most distressing human cancers, causing pain and affecting the basic survival functions of breathing and swallowing. Mortality rates have not changed despite recent advances in radiotherapy and surgical treatment. We have compared the expression of over 13,000 unique genes in 7 cases of matched HNSCC and normal oral mucosa. Of the 1,260 genes that showed statistically significant differences in expression between normal and tumor tissue at the mRNA level, the three top ranking of the top 5% were selected for further analysis by immunohistochemistry on paraffin sections, along with the tumor suppressor genes p16 and p53, in a total of 62 patients including 55 for whom >4‐year clinical data was available. Using univariate and multivariate survival analysis, we identified SPARC/osteonectin as a powerful independent prognostic marker for short disease‐free interval (DFI) (p < 0.002) and poor overall survival (OS) (p = 0.018) of HNSCC patients. In combination with other ECM proteins found in our analysis, PAI‐1 and uPA, the association with DFI and OS became even more significant (p < 0.001). Our study represents the first instance of SPARC as an independent prognostic marker in HNSCC.Keywords
This publication has 24 references indexed in Scilit:
- Current Applications of Microarrays in Head and Neck Cancer ResearchThe Laryngoscope, 2004
- Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysisOral Oncology, 2003
- Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cellsOncogene, 2002
- Induction of SPARC by VEGF in Human Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 2001
- Transforming growth factor β1, urokinase‐type plasminogen activator and plasminogen activator inhibitor‐1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosaHead & Neck, 2001
- Distribution of SPARC in normal and neoplastic human tissue.Journal of Histochemistry & Cytochemistry, 1995
- Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genesInternational Journal of Cancer, 1995
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.The Journal of cell biology, 1993
- Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991